| Literature DB >> 31210080 |
Mona Badawy1, Anne Marie Fenstad2, Ove Furnes2,3,4.
Abstract
Background and purpose - The number of primary, highly constrained knee arthroplasty implants has increased with a theoretically increased risk of early failure. Therefore we analyzed the risk of all revision following total knee arthroplasty (TKA) in patients receiving a hinged or condylar constrained knee (CCK) compared with a conventional unconstrained TKA. Patients and methods - The analyses included 401 primary highly constrained or hinged implants from 1994 to 2017. Kaplan-Meier survival curves were used to evaluate time to first revision with a maximum follow-up of 20 years. Cox regression was used to calculate hazard ratio (HR) comparing condylar constrained knee (CCK), hinged, and unconstrained TKA. Results - Kaplan-Meier estimated prosthesis survival after 2 years was 94.8% (95% CI 91.4-98.2) and 93.5% after 5 years for the primary CCK and 91.0% (CI 86.6-95.4) after 2 years and 85.5% after 5 years for the primary hinged TKA. Adjusted for sex, age groups, diagnosis, time period, previous surgery, and surgery time HR was 1.4 (CI 0.8-2.3) for the CCK and 2.4 (CI 1.6-3.7) for the hinged implants. The most common cause of revision in hinged implants was infection: 14 of 22 revisions. When excluding infection as revision cause, there were no differences in survival between the implant types. Estimated survival excluding infection revisions at 5 years was 96% for unconstrained, CCK, and hinged primary TKA implants. Interpretation - Primary rotating hinge total knee arthroplasty had a higher risk of revision compared with conventional TKA after 2 and 5 years' follow-up. Infection was the most common cause of revision. When excluding infection revisions from the survival analysis, hinged and CCK implants had similar performance to unconstrained TKA.Entities:
Mesh:
Year: 2019 PMID: 31210080 PMCID: PMC6746286 DOI: 10.1080/17453674.2019.1627638
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.401 cases of constrained or hinged implants were included from the Norwegian Arthroplasty Register from 1994 to 2017. 53 cases were excluded due to oncological indication for surgery. digits are number of implants.
Figure 2.Increasing usage of primary CCK and hinged TKA in the from 1994 to 2017 in the Norwegian Arthroplasty Register.
Demographic data (n = 71,916) by TKA implant type from 1994 to 2017. Values are frequency (%) unless otherwise specified
| Hinged | CCK | Unconstrained | p-value | |
|---|---|---|---|---|
| Primary procedures | 197 | 204 | 71,515 | |
| Revisions | 22 (11) | 14 (7) | 3,565 (5) | < 0.001 |
| Male sex | 55 (28) | 58 (28) | 25,423 (36) | 0.008 |
| Age, years mean/median range | 67/70 | 67/68 | 69/70 | < 0.001 |
| 22–90 | 25–95 | 16–101 | ||
| Age groups (%) | < 0.001 | |||
| < 50 | 14 | 11 | 4 | |
| 50–60 | 15 | 17 | 14 | |
| 60–70 | 23 | 28 | 32 | |
| 70–80 | 32 | 27 | 38 | |
| > 80 | 16 | 17 | 12 | |
| Diagnosis | < 0.001 | |||
| Primary OA | 64 (33) | 109 (53) | 59,023 (83) | |
| Inflammatory arthritis | 15 (8) | 15 (7) | 4,347 (6) | |
| Post-fracture arthritis | 28 (14) | 22 (11) | 1,926 (3) | |
| Post ligament injury | 37 (19) | 38 (19) | 5,161 (7) | |
| Post infection | 9 (5) | 5 (2.5) | 232 (0.3) | |
| Instability | 13 (6) | 1 (0.5) | 49 (0.1) | |
| Neuro orthop. sequelae | 10 (5) | 2 (1) | 25 (0.1) | |
| Other | 20 (10) | 12 (6) | 627 (0.5) | |
| Time period | < 0.001 | |||
| 1994–2007 | 15 (8) | 21 (10) | 25,942 (36) | |
| 2008–2017 | 182 (92) | 183 (90) | 45,573 (64) | |
| Surgery time | < 0.001 | |||
| median (IQR) | 150 (55) | 145 (55) | 90 (35) | |
| range | 85–420 | 80–360 | 31–654 | |
| ASA classification | < 0.001 | |||
| ASA 1 | 16 (9) | 14 (8) | 7,313 (14) | |
| ASA 2 | 94 (51) | 107 (58) | 35,066 (66) | |
| ASA 3+ | 74 (40) | 64 (33) | 10,587 (20) | |
| Previous surgery | < 0.001 | |||
| None | 122 (62) | 127 (62) | 50,788 (71) | |
| Fracture | 34 (17) | 29 (14) | 1,402 (2) | |
| Ligament | 20 (10) | 19 (9) | 9,005 (13) | |
| Osteotomy | 4 (2) | 11 (5) | 2,393 (39 | |
| Other | 17 (9) | 18 (9) | 7,927 (11) | |
| Perioperative complications | 7 (3.6) | 17 (8.5) | 1,331 (1.9) | < 0.001 |
| Patellar component | 34 (17) | 40 (20) | 5,235 (7) | < 0.001 |
| Stems femur/tibia, n | 155/150 | 167/164 | 527/4,290 | |
| Augments femur/tibia, n | 16/18 | 24/16 | 785/763 |
Unconstrained TKA were procedures with cruciate retaining or posterior stabilized, mobile or fixed bearing TKA.
2-sided t-test for continuous variables. Chi-square test for categorical variables. Independent sample median test = non-parametric.
Diagnosis missing n = 126, surgery time missing n = 1,813, and perioperative complications missing n = 1,275.
From 2005, n = 53,335
TKA with patellar component
18% of information regarding use of stems was missing for hinged implants, 15% missing for CCK, and 42% missing for unconstrained TKA in the registry data.
58% of information regarding use of augments was missing for hinged implants, 56% missing for CCK, and 43% missing for unconstrained TKA in the registry data.
Primary TKA with tumor indication were removed from the data material (n = 40 hinged, n = 2 CCK, n = 11 unconstrained).
Figure 3.Kaplan–Meier survival curve with revision for any reason (a) and excluding infection revision (b) from 1994 to 2017 for TKA by implant type; blue = primary hinged knee replacement, red = primary condylar constrained knee replacement, black = unconstrained total knee replacement.
Kaplan–Meier survival free of all cause revision at 2, 5, and 10 years postoperatively
| No. of patients | No. of revisions (%) | No. of deaths (%) | No. at risk | K–M 2-yea survival (CI) | No. of risk | K–M 5-year survival (CI) | No. at risk | K–M 10-year survival (CI) | |
|---|---|---|---|---|---|---|---|---|---|
| Unconstrained | 71,515 | 3,565 (5) | 15,669 (22) | 57,585 | 97 (97–98) | 39,936 | 95 (95–96) | 17,379 | 94 (94–94) |
| CCK | 204 | 14 (7) | 31 (15) | 128 | 95 (91–98) | 57 | 94 (89–98) | 8 | 79 (62–96) |
| Hinged | 197 | 22 (11) | 19 (10) | 115 | 91 (87–95) | 58 | 86 (79–92) | 8 | 84 (77–91) |
Kaplan–Meier survival (%) with 95% CI in parentheses for all-cause reoperation for the entire follow-up period.
Unadjusted and adjusted hazard ratio
| Unadjusted HR | Adjusted HR | |
|---|---|---|
| Unconstrained | 1 (ref.) | 1 (ref.) |
| CCK | 2.0 (1.2–3.3) | 1.4 (0.8–2.3) |
| Hinged | 3.3 (2.2–4.9) | 2.4 (1.6–3.7) |
Hazard ratio is shown unadjusted and adjusted for sex, age groups, diagnosis, time period, surgery time, previous surgery to the knee, perioperative complications, and ASA classification (registered since 2005 in the register).
Number at risk (Figure 3)
| Year | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hinged | 197 | 154 | 116 | 86 | 67 | 59 | 47 | 30 | 19 | 15 | 9 |
| CCK | 204 | 153 | 128 | 108 | 82 | 57 | 37 | 27 | 19 | 10 | 8 |
| Unconstrained | 71,515 | 64,503 | 57,585 | 51,179 | 45,282 | 39,937 | 34,792 | 30,132 | 25,584 | 21,166 | 17,380 |